肿瘤光动力治疗临床应用的光敏剂及其研究概况

doi:10.3724/SP.J.1095.2013.30375

摘要/Abstract

摘要： 光动力治疗是一种非侵蚀性并具有一定靶向性的肿瘤治疗新方法。光动力治疗需要光敏剂、光和氧结合产生光动力反应。光敏剂是光动力治疗的关键和物质基础。本文概括介绍了已上市的和已被批准进入临床试验中的光敏剂，并根据其分子的骨架结构，将其分为分卟啉类、二氢卟吩（叶绿素）类和菌绿素/酞菁三类。同时从理想光敏剂应具备特点出发，探讨了研究中的光敏剂和光动力治疗的发展前景。

关键词: 光动力治疗, 光敏剂, 光敏剂类型, 光敏剂结构, 光动力反应

Abstract: Photodynamic therapy(PDT) has emerged as a selective and non-invasive modality for the treatment of malignant tumors. Photosensitizers are the key component of PDT, which generates cytotoxic reactive oxygen species(ROS) in the presence of oxygen and light with appropriate wavelength. In clinical practice, three families of photosensitizer(PS) are used, including porphyrins, chlorophylls and bacteriochloyin/phthalocyanines. This review focused on the oncologic photosensilizers that were in clinical uses or trials and from the points of view of successful photosensitizers explored the future trends of PS and PDT.

Key words: photodynamic therapy, photosensitizer, photosensitizer types, photosensitizer structure, photodynamic reaction

中图分类号:

O622.6

刘宏, 薛金萍, 江舟, 陈耐生, 黄金陵. 肿瘤光动力治疗临床应用的光敏剂及其研究概况[J]. 应用化学, DOI: 10.3724/SP.J.1095.2013.30375.

LIU Hong, XUE Jinping, JIANG Zhou, CHEN Naisheng*, HUANG Jinling*. Photosensitizer Used in Clinical Photodynamic Thearpy for Cancer[J]. Chinese Journal of Applied Chemistry, DOI: 10.3724/SP.J.1095.2013.30375.

参考文献

[1] Dougherty T J. Photodynamic Therapy(PDT) of Malignant Tumors[J]. Crit Rev Oncol Hematol,1984,2:83-116.

[2] Brown S. Photodynamic Therapy:Two Photons are Better than One[J]. Nat Photon,2008,2:394-395.

[3] Idris N M,Gnanasammandhan M K,Zhang J,et al. In vivo Photodynamic Therapy Using Upconversion Nanoparticles as Remote-controlled Nanotransducers[J]. Nat Med,2012,18:1580-1585.

[4] Brasseur N,Ali H,Autenrieth D,et al. Biological Activities of Phthalocyanines-Ⅲ.Photoinactivation of V-79 Chinese Hamster Cells by Tetrasulfophthalocyanines[J]. Photochem Photobiol,1985,42:515-521.

[5] Jia X,Yang F F,Li J,et al. Synthesis and in Vitro Photodynamic Activity of Oligomeric Ethylene Glycol-Quinoline Substituted Zinc(Ⅱ) Phthalocyanine Derivatives[J]. J Med Chem,2013,56:5797-5805.

[6] Dennis E J,Dolmans G J,Dai F,et al. Photodynamic Therapy for Cancer[J]. Nat Rev Cancer,2003,3(3):380-387.

[7] Charles J G. Photodynamic Therapy-methods and Protocols[M]. New York:Humana Press,2010:26-28.

[8] Allison R R,Downie G H,Cuenca R,et al. Photosensitizers in Clinical PDT[J]. Photodiagnosis Photodyn Ther,2004,1:27-42.

[9] Mroz P,Yaroslavsky A,Kharkwal G B,et al. Cell Death Pathways in Photodynamic Therapy of Cancer[J]. Cancers,2011,3:2516-2539.

[10] Oleinick N L,Morris R L,Belichenko I. The Role of Apoptosis in Response to Photodynamic Therapy:What, Where, Why, and How[J]. Photochem Photobiol Sci,2002,1:1-21.

[11] Igney F H,Krammer P H. Death and Anti-death:Tumour Resistance to Apoptosis[J]. Nat Rev Cancer,2002,2:277-288.

[12] Boyle R W,Dolphin D. Structure and Biodistribution Relationships of Photodynamic Sensitizers[J]. Photochem Photobiol,1996,64:469-485.

[13] Hamblin M R,Newman E L. On the Mechanism of the Tumour-localising Effect in Photodynamic Therapy[J]. J Photochem Photobiol B,1994,23:3-8.

[14] Jori G,Reddi E. The Role of Lipoproteins in the Delivery of Tumour-targeting Photosensitizers[J]. Int J Biochem,1993,25:1369-1375.

[15] Castano A P,Demidova T N,Hamblin M R. Mechanisms in Photodynamic Therapy:Part Three. Photosensitizer Pharmacokinetics, Biodistribution, Tumor Localization and Modes of Tumor Destruction[J]. Photodiagnosis Photodyn Ther,2005,2:91-106.

[16] Castano A P,Demidova T N,Hamblin M R. Mechanisms in Photodynamic Therapy:Part Two.Cellular Signaling, Cell Metabolism and Modes of Cell Death[J]. Photodiagnosis Photodyn Ther，2005，2:1-23.

[17] Juarranz A,Jaen P,Sanz-Rodriguez F,et al. Photodynamic Therapy of Cancer. Basic Principles and Applications[J]. Clin Transl Oncol,2008,10(3):148-154.

[18] Ron R A,Claudio H S. Oncologic Photodynamic Therapy Photosensitizers:A Clinical Review[J]. Photodiagnosis Photodyn Ther,2010,7:61-75.

[19] Ron R A,Gordon H D,Rosa Cuenca,et al. Photosensitizers in Clinical PDT[J]. Photodiagnosis Photodyn Ther,2004,1:27-42.

[20] Huang Z. An Update on the Regulatory Status of PDT Photosensitizers in China[J]. Photodiagnosis Photodyn Ther,2008,5:285-287.

[21] Allison R R,Sibata C H. Photodiagnosis for Cutaneous Malignancy:A Brief Clinical and Technical Review[J]. Photodiagnosis Photodyn Ther,2008,5:247-250.

[22] Michael R D,Scott L G,Stephen J W. Current Clinical and Preclinical Photosensitizers for Use in Photodynamic Therapy[J]. J Med Chem,2004,47(16):3897-3915.

[23] LI Xufei,XUE Jinping,CHEN Naisheng,et al. Photo-generating Singlet Oxygen Ability of Metallophthalocyanines Substituted with Aromaticoxy Group Containing Nitrogen[J]. Chinese J Appl Chem,2007，24（9）:1041-1044(in Chinese).

李旭飞,薛金萍,陈耐生,等. 含氮芳氧基取代酞菁金属配合物光敏产生1O2的研究[J]. 应用化学,2007，24（9）:1041-1044.

[24] Xue J P,Cai L X,Chen N S，et al. Synthesis and Photophysical Properties of Zinc Phthalocyanines Substituted with Quinolinoxy Group[J]. J Porphyrins Phthalocyanines,2009,13:1206-1213.

[25] Nagao Kobayashi,Hiroshi Ogata,Naokazu Nonaka,et al. Effect of Peripheral Substitution on the Electronic Absorption and Fluorescence Spectra of Metal-Free and Zinc Phthalocyanines[J]. Chem Eur J,2003,9:5123-5134.

[26] HUANG Jingling,HUANG Jiandong,LIU Ersheng,et al. Some Relationships Between Structures and Photodynamic Anti-cancer Activities of Phthalocyanines[J]. Acta Phys-Chim Sin,2001,17(7):662-671(in Chinese).

黄金陵，黄剑东，刘尔生，等. 酞菁配合物的结构与其光动力抗癌活性[J]. 物理化学学报，2001,17(7):662-671.

[27] Tebello Nyokong. Effects of Substituents on the Photochemical and Photophysical Properties of Main Group Metal Phthalocyanines[J]. Coord Chem Rev,2007,251:1707-1722.

[28] Ishii K,Kobayashi N. In:Kadish K M,Smith K M,Guilard E,Eds. [M] The Porphyrin Handbook,Chapter 1,vol. 16,Elsevier,2003(chapter 1).

[29] Raymond Bonnett. Chemical Aspects of Photodynamic Therapy[M]. Gordon and Breach Science Pulishers,(Australia Canada France Germany India Japan Luxembourg Malaysia The Netherlands Russia Singapore Switzerland),2000,1:144.

[30] Mang T S. Lasers and Light Sources for PDT:Past, Present and Future[J]. Photodiagnosis Photodyn Ther,2004,1:43-48.

[31] Allison R R. Future PDT[J]. Photodiagnosis Photodyn Ther,2009,6:231-234.

[32] Allison R R,Bagnato V S,Sibata C H. Future of Oncologic Photodynamic Therapy[J]. Future Oncol,2010,6:929-940.

[33] Ron R A,Keyvan M. Photodynamic Therapy(PDT):PDT Mechanism[J]. Clin Endosc,2013,46:24-29.

[34] Nawal S,Hubert van den B,Norbert L. Like a Bolt from the Blue:Phthalocyanines in Biomedical Optics[J]. Molecules,2012,17:98-144.

[35] Chen B,Roskams T,de Witte P A. Antivascular Tumor Eradication by Hypericin-mediated Photodynamic Therapy[J]. Photochem Photobiol,2002,76:509-513.